InMode Ltd vs Raytheon Technologies Corp — how do they compare? InMode Ltd trades at $14.2 (market cap $809.93M), while Raytheon Technologies Corp trades at $185.62 (market cap $248.42B). The key difference: Raytheon Technologies Corp is far larger — about 306.7× InMode Ltd's market cap, and Raytheon Technologies Corp pays a 1.58% dividend while InMode Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold InMode Ltd for 28 Days and Raytheon Technologies Corp for 77 Days on average.
| INMD | RTX | |
|---|---|---|
Market Cap | $809.93M | $248.42B |
Volume | 365,490 | 4,380,368 |
Sector | Health | Industrials |
52-Week High | $16.62 | $225.49 |
52-Week Low | $12.76 | $157.00 |
Typical Hold Time | 28 Days | 77 Days |
Enterprise Value | $313.27M | $278.97B |
Dividend Yield | — | 1.58% |
Signals from Pluang's Aura AI — not financial advice
INMD trades at $14.14, up 0.93% on the day, with bearish technical signals from moving averages but attractive valuation metrics including a P/E of 11.63 and EV/EBITDA of 4.48. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1 2026, while maintaining strong profitability with 76.52% gross margins. Recent developments include the launch of Morpheus8 Cool technology and an unsolicited acquisition offer from Steel Partners at $16.75 per share.
The stock presents value opportunity with solid fundamentals but faces near-term headwinds from cyclical industry softness and management capital allocation concerns. Analyst sentiment is divided with 45% buy ratings versus 55% hold, suggesting cautious optimism amid ongoing strategic review of the acquisition proposal.
RTX trades at $180.26, down 1.65% today, amid a bearish technical signal but strong fundamental performance. The company reported three consecutive quarterly earnings beats, with Q3 2026 EPS expected at $1.77. Revenue grew to $88.6B in 2025, with net income margin improving to 7.59%. Analyst consensus remains strongly bullish with a $236.27 price target and 65% buy ratings, supported by a $289B backlog and defense sector tailwinds.
The outlook for RTX is positive given robust defense spending, earnings momentum, and analyst confidence. Risks include execution on large contracts, debt levels, and geopolitical uncertainties. The stock offers growth potential with a 30% upside to consensus target, but investors should monitor quarterly execution and defense budget developments.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Read more on INMD →Raytheon Technologies is a diversified aerospace and defense industrial company formed from the merger of United Technologies and Raytheon, with roughly equal exposure as a supplier to commercial aerospace manufactures and to the defense market as a prime and subprime contractor.
Read more on RTX →